News
EQS-News: CHAPTERS platform Altamount Software GmbH successfully completes acquisition of PSI Transcom GmbH
voxeljet AG - Extraordinary General Meeting – First Shareholder Meeting Regarding the Sale of voxeljet’s Business Concluded
Today, voxeljet AG (“voxeljet”) announced that at the extraordinary General Meeting of voxeljet AG on Thursday, February 27, 2025, voxeljet completed the first shareholder meeting with resolutions
Median Technologies to Present at TD Cowen’s 45th Annual Health Care Conference
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA/SME eligible, “Median” or “The Company”), a leading developer of eyonis™, a suite of artificial intelligence (AI) powered Software
BILENDI: Bilendi in 2024: a year of transformation and major strategic breakthroughs
Median Technologies to Showcase Its Artificial Intelligence Software as a Medical Device for Lung Cancer Screening, eyonis™ LCS, at the European Congress of Radiology
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA/SME eligible, “Median” or “The Company”), a leading developer of eyonis™, a suite of artificial intelligence (AI) powered Software
Hardman & Co publication on accesso Technology Group (ACSO): We expect revenue growth to accelerate
BILENDI: The latest version of Bilendi Discuss fully automates market research studies from initial objective to final report using AI
BILENDI: Bilendi announces the completion of the acquisition of Netquest
Median Technologies: eyonis™ Lung Cancer Screening (LCS) Meets Primary Endpoint in RELIVE Clinical Trial, the Final Pivotal Study Required for Regulatory Submissions
Regulatory News:
Median Technologies (Paris:ALMDT):
Fredrik Brag, CEO of Median Technologies, will host two webcasts on February 4, 2025
“New Horizons in Fighting Lung Cancer: eyonis™ LCS
Median Technologies Reports 2024 Key Financial Indicators and 2025 Outlook
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA/SME scheme eligible), a leading developer of eyonis™, a suite of artificial intelligence (AI) powered Software as a Medical Device
Median Technologies securing up to €47.5 million to support AI lung cancer diagnostic eyonis™ regulatory filings and commercialization in U.S. and EU
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA/SME eligible, “Median” or “The Company”), a leading developer of eyonis™, a suite of artificial intelligence (AI) powered Software
BILENDI: Launch of Bilendi Platform: Redefining Efficiency in Market Research
Median Technologies: Financial Communications Schedule for the First Half of 2025
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible), announces the publication date for its 2024 results:
Publication
Date
2024
BILENDI: Bilendi launches a US panel as part of its panel expansion strategy
GLORY Confirmed as Global Leader in Retail Cash Recycling Solutions by RBR Data Services
According to the newly published Global Retail Cash Automation 2025 study from RBR Data Services, a division of research and consulting firm Datos Insights, GLORY (TYO:6457) continues to lead the
Form 8.3 - Opening Position Disclosure - Team Internet Group PLC
EQS-News: Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
EQS-News: EasyVista Successfully Completes Acquisition of a Majority Shareholding in OTRS Group, Reaffirming its Ambition to Become a Global Leader in IT Solutions
EQS-Adhoc: OTRS AG: Closing of agreements for the acquisition of a majority stake of over 90% in OTRS AG by Optimus BidCo AG, an acquisition company of Easyvista SAS
BILENDI: Bilendi announces the acquisition of Netquest, leader in technologies and data for market research in Iberia and Latin America
Jetzt zugreifen: KOORUI Gaming Monitor 24 Zoll zum Spitzenpreis!
Kaufe das MSI PRO Z890-A WiFi Mainboard: Jetzt 31% günstiger!
Spare 24% auf die Russell Hobbs Heißluftfritteuse XXL 8L – Deine perfekte Küchenhilfe jetzt zum Sonderpreis!
Jetzt zugreifen: Amazon Fire Max 11-Tablet – Leistungsstärke zum Sonderpreis!
Jetzt zugreifen: Amazon Fire Max 11-Tablet zum unschlagbaren Preis - 32% Ersparnis!